Max Dohrn

from Wikipedia, the free encyclopedia

Max Dohrn (born August 30, 1874 in Farnroda , † June 17, 1943 in Rothaus (Grafenhausen) ) was a German chemist.

Max Dohrn was a son of the insurance director Wilhelm Dohrn (1839–1903). He studied in Berlin, Leipzig and Heidelberg with his doctorate in 1899, was an assistant in Marburg and Berlin and joined the Schering factory in Berlin in 1902 as a chemist .

At Schering he developed the gout drug atophan ( phenylquinoline carboxylic acid ) (1905), which was used clinically as cinchophene from 1908 , and sulfonamides such as albucid and globucid (sulfa-5-ethyl-thiodiazole). He also dealt with human sex hormones and extracts from calf pancreas for the treatment of diabetes mellitus (Acomatol, cooperation with the doctor Georg Ludwig Zülzer ). Dohrn was elected a member of the Leopoldina in 1940 .

literature

Individual evidence

  1. William Charles Kuzell, Guy-Pierre Gaudin: gout. (= Documenta Rheumatologica. Volume 10). JR Geigy, Basel 1956, p. 11.
  2. Karl Wurm, AM Walter: Infectious Diseases. In: Ludwig Heilmeyer (ed.): Textbook of internal medicine. Springer-Verlag, Berlin / Göttingen / Heidelberg 1955; 2nd edition ibid. 1961, pp. 9–223, here: p. 45 ( Globucid from Schering and sulfa-perlongite from Boehringer I.)